GENESPIRE
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
GENESPIRE
Industry:
Biotechnology Life Science
Founded:
2020-03-01
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.genespire.com
Total Employee:
1+
Status:
Active
Contact:
39 02 83991300
Email Addresses:
[email protected]
Total Funding:
16 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series A - Genespire
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-07 | Genespire appoints Dr. Sabah Sallah as Chief Medical Officer |
Official Site Inspections
http://www.genespire.com
- Host name: carnage.evtel.com
- IP address: 18.156.43.197
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Genespire"
The company - Genespire
Genespire is led by an experienced and international management team with experience from renowned biotech companies and world-class biopharmaceutical organizations. The company …See details»
Genespire - Crunchbase Company Profile & Funding
Organization. Genespire . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Genespire is a biotechnology company focused on the development of transformative gene …See details»
Board of Directors - Genespire
Karen Aiach-Pignet joined Genespire as Chief Executive Officer in September 2024. She has an outstanding track-record in gene therapy applied to genetic neurodegenerative diseases …See details»
Genespire Company Profile 2024: Valuation, Funding & Investors
Genespire General Information Description. Developer of transformative gene therapies designed to treat patients affected by severe genetic diseases. The company's therapies combine …See details»
Genespire - Milano, Italy
Oct 1, 2024 Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary …See details»
Genespire - Funding, Financials, Valuation & Investors - Crunchbase
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases. ... How much funding has this organization …See details»
GeneSpire - Products, Competitors, Financials, Employees, …
Eyes on Europe: Asabys’ €180M fund, Genespire’s record series B. Sep 27, 2024. Eyes on Europe: Asabys’ €180M fund, Genespire’s record series B BioCentury’s weekly Venture …See details»
Genespire Company Profile - Office Locations, Competitors ... - Craft
Genespire has 5 employees at their 1 location and $17.34 m in total funding,. See insights on Genespire including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Genespire - Crunchbase
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases. Search Crunchbase. Start Free Trial . …See details»
Genespire - Company Profile - Tracxn
Nov 26, 2024 Genespire ranks 149th among 791 active competitors. 293 of its competitors are funded while 144 have exited. Overall, Genespire and its competitors have raised over $24.1B …See details»
Genespire Company Information - Funding, Investors, and More
The company Genespire has raised a total of $52m in funding over 1 rounds. Key Insights: Series B: $52m; 2024. Genespire Series B round, September 2024 $52m. Discover Genespire. …See details»
Genespire | The Pharmaletter
Sep 25, 2024 Genespire is initially advancing therapeutic programs in inherited metabolic diseases with high unmet medical need. Based in Milan, Italy, Genespire was founded in …See details»
Genespire S.r.l. - life-sciences-europe.com
Mar 1, 2020 Genespire is initially advancing therapeutic programs in inherited metabolic diseases with high unmet medical need. Based in Milan, Italy, Genespire was founded in …See details»
Genespire - Contacts, Employees, Board Members, Advisors
Organization. Genespire . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of Board …See details»
Genespire — Sofinnova Partners
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies …See details»
Our science - Genespire
Genespire develops transformative gene therapies for inherited metabolic diseases and for primary immune deficiencies, based on two innovative technology platforms: the “immune …See details»
An Italian biotech gets $52M to advance pediatric gene therapies
Sep 25, 2024 Genespire is specifically targeting pediatric conditions, where the long-lasting effects of lentiviral therapies might offer unique advantages over other so-called viral vectors. …See details»
Overview - Genespire
Genespire has generated a novel proprietary class of lentiviral vectors, the Immune Shielded Lentiviral Vectors (ISLVs), which are masked from the patient’s immune system. They are …See details»
What Is Minicircle? Bryan Johnson's Honduras Gene Therapy …
10 hours ago Don't Die: The Man Who Wants to Live Forever is Netflix's new documentary film about Bryan Johnson's anti-aging attempts, and here's what the Minicircle gene therapy …See details»
Programs - Genespire
Genespire is developing GENE202, an ISLV-based gene therapy, to treat patients affected by methylmalonic acidemia (MMA).. MMA is a rare genetic disease characterized by significant …See details»